Structural Biology in Drug Design

Drug design is an innovative process to asset new medication based on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design are not essential for relies on computational methods. This kind of modelling is often indicated as computer-assisted drug design. Drug design which depends on the knowledge of the 3D structure of the target is known as structure-based drug design. The main methods available for drug design are structure based drug design and ligand based drug design.

 

  • 21-1. Drug targets
  • 21-1. Computer-aided drug design
  • 21-3. Ligand-based design
  • 21-4. Structure-based design
  • 21-5. Binding site identification
  • 21-6. Scoring functions

Related Conference of Structural Biology in Drug Design

Structural Biology in Drug Design Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in